Cerene Cryotherapy Device
Channel Medsystems, Inc. · Decision date Jul 8, 2026
What did the FDA approve?
FDA records P180032/S023 as a supplement to PMA P180032, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Jul 8, 2026.
FDA approval order statement
The recommended decision for this file is Approve PMA GMP without inspection. This recommendation is based on transferring a low-risk labeling activity to a manufacturing site (and sponsor) previously approved under the PMA.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Jul 8, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P180032/S023
- Regulatory pathway
- PMA supplement
- Applicant
- Channel Medsystems, Inc.
- Product code
- MNB
- Decision code
- APPR
- Decision date
- Jul 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, thermal ablation, endometrial.
- Applicant
- Channel Medsystems, Inc.
- Product code
- MNB
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P180032. Subsequent supplements may change the device or its indications.
FDA decision timeline
P180032 · Original PMA
Cerene Cryotherapy Device
P180032/S022 · Related supplement
Cerene Cryotherapy Device
P180032/S023 received
Application receipt date recorded by FDA.
P180032/S023 · FDA decision
Normal 180 Day Track
P180032/S024 · Related supplement
Cerene Cryotherapy Device
P180032/S025 · Related supplement
Cerene Cryotherapy Device (Model number FGS-7000); Exhaust Collection Bag (Model number FGS-8000); Exhaust Collection Ba
Timeline entries are records held by MedtechLedger for P180032. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P180032
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Cerene Cryotherapy DeviceP180032 | Channel Medsystems, Inc. | PMA approval | Mar 28, 2019 | FDA |
Cerene Cryotherapy DeviceP180032/S022 | Channel Medsystems, Inc. | PMA supplement | Dec 18, 2025 | FDA |
Cerene Cryotherapy DeviceP180032/S024 | Channel Medsystems, Inc. | PMA supplement | Sep 15, 2026 | FDA |
| Channel Medsystems, Inc. | PMA supplement | Nov 3, 2026 | FDA |
Explore the linked device profile
Other records with product code MNB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MINERVA ENDOMETRIAL ABLATION SYSTEMP140013/S019 | Axora Medical, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Minitouch 3.8 Era System (Minitouch System)P230002/S002 | MICROCUBE, LLC | PMA supplement | Jul 13, 2026 | FDA |
Minerva Endometrial Ablation SystemP140013/S018 | Axora Medical, Inc. | PMA supplement | Feb 12, 2026 | FDA |
NovaSure Model 10 RF ControllerP010013/S094 | Hologic, Inc. | PMA supplement | Dec 17, 2025 | FDA |
| Axora Medical, Inc. | PMA approval | Jul 27, 2015 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Channel Medsystems, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 5858 Horton St., Suite 200, Emeryville, CA, 94608
Sources and methodology
- Original FDA record: P180032/S023
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





